Tipsheet
What matters at India’s listed companies
Earnings · Pharmaceuticals · Micro cap

Panjon's full-year revenue surges 56%, but the last quarter contracts

Annual revenue hit ₹47.92 crore, but Q4 total income fell to ₹12.29 crore from ₹13.88 crore a year ago. Net profit for the year was ₹72.45 lakhs.

1 earlier story on Panjon Ltd.
Mkt cap₹30.45 cr
P/E50.83×
ROE2.47%
Debt / eq.0.16
56% Year-on-year revenue growth for FY26.

What's new

  • FY26 revenue surged 56% to ₹47.92 crore; net profit rose to ₹72.45 lakhs from ₹52.74 lakhs.
  • Q4 total income fell to ₹12.29 crore, down from ₹13.88 crore in the same period last year.
  • Board appointed M/s. B. Jakhetiya & CO. as internal auditor for FY27; auditors gave an unmodified opinion.

Why this matters

The 56% annual growth is a headline win for a company with a ₹38 crore market cap. But the Q4 contraction shows the momentum may be fading. For a nano-cap, quarterly swings matter less than trajectory, and this quarter interrupts it.

What we're watching

  • Whether the Q4 slowdown is a one-quarter blip or the start of a trend.
  • If the newly appointed internal auditor flags anything in the upcoming review.
  • How the company translates its revenue growth into meaningfully higher profit in FY27.

The full read

Panjon reported 56% annual revenue growth, a strong headline for a ₹38 crore nano-cap. Full-year revenue reached ₹47.92 crore, with profit rising to ₹72.45 lakhs from ₹52.74 lakhs. But the story fractures in the final quarter. Q4 total income dropped to ₹12.29 crore from ₹13.88 crore. For a small company, quarterly swings are normal, but this one interrupts the growth narrative. The board also made a routine administrative move, appointing M/s. B. Jakhetiya & CO. as the internal auditor for FY27. The statutory auditors signed off without qualification. The numbers tell two stories: one of impressive annual expansion, and one of a final quarter that lost ground.

Questions answered

How did Panjon's full-year and quarterly performance compare?
For the full year, revenue grew 56% to ₹47.92 crore. However, the fourth quarter showed weakness, with total income falling to ₹12.29 crore from ₹13.88 crore in the same period last year.
What was the profit figure for FY26?
Net profit for the year increased to ₹72.45 lakhs, up from ₹52.74 lakhs in the prior year.
What administrative changes were made during the board meeting?
The board confirmed the appointment of M/s. B. Jakhetiya & CO. as the internal auditor for the 2026-27 fiscal year. The statutory auditors also issued an unmodified opinion on the financial statements.
How large is Panjon in the market?
Panjon is a nano-cap entity with a market capitalization of approximately ₹38 crore, according to the analyst rationale.
Mentioned: Panjon Ltd. · ₹47.92 crore revenue · M/s. B. Jakhetiya & CO.
Primary source BSE · NSE · Tijori

An independent reading of the company's own disclosure — the primary filing above is the final word.

Company snapshot

Panjon Ltd.

Pharmaceuticals
₹30 cr
P/E 50.81×

Latest quarter · Mar 2026

Sales₹12 cr
Net profit₹0 cr
Op. margin+2.0%
EPS₹0.04

Strength & growth

Debt / equity0.16×
Current ratio3.69×
Sales CAGR+15.1%
Financials via Tijori — a research aid, not investment advice.PANJON on Tijori
  1. 29 May 2026 · 8:37 PM IST Panjon's full-year revenue surges 56%, but the last quarter contracts
  2. 16d ago Panjon's FY26 results get clean audit, but no surprises